---
$id: https://graph.org.ai/products/commodity/51263149
$type: Product
source: UNSPSC
code: "51263149"
title: "Betaxolol hydrochloride"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Betaxolol hydrochloride

**UNSPSC Code**: 51263149
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula C18H29NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6X97D2XT0O, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)- but more generally known as betaxolol hydrochloride, which bears US NIH Compound Identifier 107952. European Medicines Agency schedules Betaxolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13062MIG. Most nations, for tariff and trade purposes, schedule betaxolol hydrochloride under HS 29221980. As of Q4 2014, BETAXOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Betaxolol hydrochloride bears US NLM identifiers UMLS ID C0699055 and NCI Concept Code C47413. SMILES: CC(C)NCC(COC1CCC(CC1)CCOCC2CC2)O.CL.

